Log In

Status Information

Status
DISCOURAGED

Term Description

Measurement of respondent's lifetime use of illicit and prescribed substances. Respondents will answer yes or no to the following list of drugs. If he or she indicates that he or she has used a specific drug (even experimentally), the interviewer will query for the specific drug(s) used. Note that the protocol specified below has been adapted so that the names of the drug categories are listed as noted in Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) survey (see Source below). In Wave 1, each drug category was phonetically spelled out for the interviewer.

Reference Information

TypeSourceReference
ArticleConsensus measures for Phenotypes and ExposuresGrant, B. F., Harford, T. C., Dawson, D. A., Chou, P. S., & Pickering, R. P. (1995). The Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): Reliability of alcohol and drug modules in a general population sample. Drug and Alcohol Dependence, 39(1), 37-44.
ArticleConsensus measures for Phenotypes and ExposuresHasin, D., Carpenter, K. M., McCloud, S., Smith, M., & Grant, B. F. (1997). The Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): Reliability of alcohol and drug modules in a clinical sample. Drug and Alcohol Dependence, 44(2-3), 133-141.
ArticleConsensus measures for Phenotypes and ExposuresGrant B. F., Dawson, D. A., Stinson, F. S., Chou, P. S., Kay, W., & Pickering, R. (2003). The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): Reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug and Alcohol Dependence, 71(1), 7-16.
CitationConsensus measures for Phenotypes and ExposuresNational Institute on Alcohol Abuse and Alcoholism (NIAAA) National Epidemiologic Survey on Alcohol and Related Conditions. Wave 1 (NESARC - WAVE 1). Alcohol Use Disorder and Associated Disabilities Interview Schedule - Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition Version (AUDADIS-IV), Section 3B (question 1a).

Panel Hierarchy

Details for each LOINC in Panel LHC-Forms

LOINCNameR/O/CCardinalityExample UCUM Units
62505-3PhenX - substance - lifetime use protocol 031101
Indent63663-9Have you ever used any of these drugs to feel good or high, or to feel more active or alert? Or did you use any prescription drugs when they were not prescribed, or more than prescribed?
Indent63643-1Drug type used in your lifetime

LOINC Names Get Info

Fully-Specified Name
PhenX - substance - lifetime use protocol 031101:-:Pt:^Patient:-:PhenX
Long Common Name
PhenX - substance - lifetime use protocol 031101
Short Name
Substance - lifetime use proto

Part Model Get Info

  • Component
    PhenX - substance - lifetime use protocol 031101
    LP111683-1
    • Analyte
      PhenX - substance - lifetime use protocol 031101
      LP111683-1
      • Component Numerator
        PhenX - substance - lifetime use protocol 031101
        LP111683-1
        • Component Numerator Core
          PhenX - substance - lifetime use protocol 031101
          LP111683-1
        • Component Numerator Core Suffix
          NULL
           
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    -
    LP6769-6
  • Time
    Pt
    LP6960-1
  • System
    ^Patient
    LP310005-6
    • System Core
      NULL
       
    • Super System
      Patient
      LP6985-8
  • Scale
    -
    LP7747-1
  • Method
    PhenX
    LP95333-8

Survey Question

PX031101

Basic Attributes

Class
PANEL.PHENX
Type
Clinical
First Released
Version 2.36
Last Updated
Version 2.81 (MIN)
Change Reason
Release 2.81: Status: Changing concept status from Trial to Discouraged upon recommendation from RTI; concept is deprecated in PhenX toolkit; Previous Releases: Updated the PhenX ID from "PhenX.<ID>" to "PX<ID>" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.; Added the PhenX protocol ID to the Component to clearly define the protocol version for which this panel is based upon.
Panel Type
Panel

Member of these Panels

LOINCLong Common Name
62541-8PhenX domain - Alcohol, tobacco and other substances

Language Variants Get Info

TagLanguageTranslation
el-GRGreek (Greece)PhenX - ουσία - χρήση καθ' όλη τη διάρκεια της ζωής πρωτόκολλο 031101:-:Pt:^Ασθενής:-:PhenX
Synonyms: - PANEL.PHENX PHENX PhenX - ουσία - χρήση καθ'' όλη τη διάρκεια της ζωής πρωτόκολλο 031101 Pt Ασθενής Ουσία
es-MXSpanish (Mexico)PhenX - Sustancia - Protocolo de uso de por vida 031101:-:Punto temporal:^ Paciente:-:PhenX
it-ITItalian (Italy)PhenX - sostanza - uso nell'arco della vita, protocollo:-:Pt:^Paziente:-:PhenX
Synonyms: Panel PhenX paziente PhenX Punto nel tempo (episodio)
ru-RURussian (Russian Federation)PhenX - вещество - на протяжении жизни употребление протокол:-:ТчкВрм:^Пациент:-:PhenX
Synonyms: Точка во времени;Момент
zh-CNChinese (China)PhenX - 物质 - 终生饮用方案 031101:-:时间点:^患者:-:PhenX
Synonyms: Consensus measures for Phenotypes and eXposures;PhenX;暴露;接触;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标 Consensus measures for Phenotypes and eXposures;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标 医嘱套餐 医嘱套餐类 医嘱套餐组 医嘱组 医嘱组.PhenX;组套（组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目）.PhenX;Consensus measures for Phenotypes and eXposures;PhenX;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标;PhenX 医嘱组 医嘱组合 医嘱组合类 医嘱组套 医嘱组套类 医嘱组类 医疗服务对象;客户;病人;病患;病号;超系统 - 病人 多重;多重型;多重标尺类型;多重精度类型 套餐 套餐医嘱 套餐医嘱组 套餐医嘱组类 实验室医嘱套餐 实验室医嘱套餐类 实验室医嘱组 实验室医嘱组合类 实验室医嘱组套 实验室医嘱组套类 实验室套餐医嘱组 实验室套餐医嘱组类 实验室检验项目医嘱组合类 实验室检验项目组合类 时刻;随机;随意;瞬间 检验医嘱组合类 检验项目医嘱组合类 检验项目组合类 组 组合 组合医嘱 组合类 组套 质

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=62505-3
Questionnaire definition
https://fhir.loinc.org/Questionnaire/?url=http://loinc.org/q/62505-3